Cargando…
Robust COX-2-mediated prostaglandin response may drive arthralgia and bone destruction in patients with chronic inflammation post-chikungunya
Patients following infection by chikungunya virus (CHIKV) can suffer for months to years from arthralgia and arthritis. Interestingly, methotrexate (MTX) a major immune-regulatory drug has proved to be of clinical benefit. We have previously shown that CHIKV can persist in the joint of one patient 1...
Autores principales: | Bedoui, Yosra, Septembre-Malaterre, Axelle, Giry, Claude, Jaffar-Bandjee, Marie-Christine, Selambarom, Jimmy, Guiraud, Pascale, Gasque, Philippe |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Public Library of Science
2021
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7920362/ https://www.ncbi.nlm.nih.gov/pubmed/33596205 http://dx.doi.org/10.1371/journal.pntd.0009115 |
Ejemplares similares
-
Quercetin can reduce viral RNA level of O’nyong-nyong virus and resulting innate immune cytokine responses in cultured human synovial fibroblasts
por: Septembre-Malaterre, Axelle, et al.
Publicado: (2021) -
Immunomodulatory drug methotrexate used to treat patients with chronic inflammatory rheumatisms post-chikungunya does not impair the synovial antiviral and bone repair responses
por: Bedoui, Yosra, et al.
Publicado: (2018) -
Methotrexate an Old Drug with New Tricks
por: Bedoui, Yosra, et al.
Publicado: (2019) -
Anti-Alphaviral Alkaloids: Focus on Some Isoquinolines, Indoles and Quinolizidines
por: Sandenon Seteyen, Anne-Laure, et al.
Publicado: (2022) -
Artemisia annua, a Traditional Plant Brought to Light
por: Septembre-Malaterre, Axelle, et al.
Publicado: (2020)